Haleon plc has grown revenue 0.53% a year over three years and 2.2% a year over five, with earnings per share compounding at 17%. Revenue growth, 3-year annual rate: +0.53% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +2.2%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +17%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 6, FY2020 to FY2025, as filed.

HLNHaleon plc

Healthcare

$9.31+3.0% 1Y

$9.31

$8.6152 weeks$11.12

Is it growing?

Good

Growing: earnings up +18% year on year and operating margin widening (+4.7 points).

2 good, 1 neutral

Revenue trend−2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+18% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+4.7 points operating

Trailing-twelve-month operating margin, 21.9% now against 17.2% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is HLN growing?

Haleon plc has grown revenue 0.53% a year over three years and 2.2% a year over five, with earnings per share compounding at 17%.

+0.53%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · growing slowly · compounded from fiscal years as filed

Revenue growth, 5-year rate: +2.2%
Revenue growth, 5-year rate · +0.53% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +17%
Earnings per share, 3-year rate · revenue +0.53% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed